Giant duodenal ulcers are extensive ulcers, more than 2.5cm in diameter, that involve a large portion of the duodenal bulb. These atypical duodenal ulcers create serious problems to the patient and the physician, are frequently complicated by bleeding and penetration, and have a high mortality rate. Most of the reported cases were classified as a severe variant of the common peptic ulcer disease, others were associated with the Zollinger Ellison syndrome. We report here four patients with giant duodenal ulcers but with a different and definitive aetiology: hepatic intra-arterial chemotherapy infusion for liver metastases or primary hepatocellular carcinoma.
Introduction
Giant duodenal ulcer is considered an atypical and dangerous variant of peptic ulcer disease. '2 The diagnostic criteria are the extension of the ulcer -more than 2.5cm in diameter -and the fact that about 80% of the bulb is involved in the ulcer cavity,3 predisposing to haemorrhage or perforation.
In the pre-endoscopic era, some cases were misdiagnosed by upper gastrointestinal X-ray series and confused with deformed bulbs or pseudodiverticula. 3 Today, combined X-ray and endoscopic studies make the diagnosis easier.
Treatment of liver metastases with hepatic intraarterial chemotherapy (HAIC), using a surgically implantable pump, has become a widespread method and was associated with improved clinical responses and survival.4'5 However, several gastrointestinal complications have been reported: erosions and ulcers in stomach and duodenum,6 biliary sclerosis7 and acalculous acute cholecystitis. 8 We describe four non-peptic patients who received intra-arterial chemotherapy for liver metastases and who developed giant duodenal ulcers. Two of them died from severe gastrointestinal bleeding. We discuss this new aetiology for giant duodenal ulcers and stress the importance of a closer endoscopic follow-up of patients undergoing intra-arterial cytotoxic treatment for early detection of gastrointestinal damage.
Materials and methods
During the period from July 1982 to December 1986, 23 patients (18 with liver metastases and 5 with primary hepatocellular carcinoma) were treated in our hospital by a selective infusion of chemotherapeutic agents through a surgically implanted hepatic artery catheter and pump. None of them had a history of peptic ulcer. During laparotomy, the gastroduodenal artery and the right gastric artery were ligated to avoid perfusion of the stomach. The drugs we used were floxuridine (FUDR) by continuous infusion in combination with intra-arterial mitomycin-C bolus. Patients with primary hepatocellular carcinoma received a bolus of adriamycin instead of mitomycin-C. The patients were followed up and if any gastrointestinal complaints or symptoms appeared a gastroscopy or X-ray series was performed.
Results
Ten patients experienced gastrointestinal problems or liver function disorders and underwent gastroscopy, upper X-ray studies or endoscopic retrograde cholangiography. In four of these patients, a giant duodenal ulcer was found. In two patients biliary sclerosis was diagnosed and in the others a moderate erosive duodenitis was disclosed by endoscopy. A clinical description of the patients with giant duodenal ulcer is presented in Table I . We conclude that giant duodenal ulcer may be induced in non-peptic patients by selective intraarterial infusion of chemotherapy for liver metastases. We stress the high mortality rate of this condition and recommend endoscopy before and after treatment, even in asymptomatic patients or those with mild, non-specific abdominal complaints. 
